Sigyn Therapeutics, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q3 2014 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Sigyn Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q3 2014 to Q3 2024.
  • Sigyn Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$1.2M, a 32.2% decline year-over-year.
  • Sigyn Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$3.99M, a 4.3% decline year-over-year.
  • Sigyn Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$4.15M, a 41.5% decline from 2022.
  • Sigyn Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$2.93M, a 2.49% increase from 2021.
  • Sigyn Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$3M, a 139% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$3.99M -$1.2M -$291K -32.2% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-19
Q2 2024 -$3.7M -$862K -$139K -19.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-19
Q1 2024 -$3.56M -$758K +$583K +43.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-19
Q4 2023 -$4.15M -$1.18M -$317K -36.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-20
Q3 2023 -$3.83M -$906K -$179K -24.7% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-19
Q2 2023 -$3.65M -$723K -$56.8K -8.52% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-19
Q1 2023 -$3.59M -$1.34M -$663K -97.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-19
Q4 2022 -$2.93M -$859K +$368K +30% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-20
Q3 2022 -$3.3M -$727K -$60.6K -9.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$3.24M -$666K -$16.5K -2.53% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-14
Q1 2022 -$3.22M -$678K -$216K -46.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-14
Q4 2021 -$3M -$1.23M -$775K -171% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$2.23M -$666K -$370K -125% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$1.86M -$650K -$389K -150% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-14
Q1 2021 -$1.47M -$462K -$211K -83.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-14
Q4 2020 -$1.26M -$452K -$450K -29063% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-21
Q3 2020 -$809K -$296K -$157K -114% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$652K -$260K -$144K -123% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-12
Q1 2020 -$508K -$251K -$305K -565% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-12
Q4 2019 -$203K -$1.55K +$1.22M +99.9% Oct 29, 2019 Dec 31, 2019 10-K 2021-04-06
Q3 2019 -$1.42M -$139K +$217K +61.1% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$1.64M -$117K +$190K +62% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 -$1.83M $54K +$793K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 -$2.62M -$1.22M -$45.4K -3.88% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-30
Q3 2018 -$2.57M -$356K +$1.14M +76.2% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$3.72M -$307K +$660K +68.2% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-05
Q1 2018 -$4.38M -$739K -$125K -20.4% Jan 1, 2018 Mar 31, 2018 10-Q 2019-04-19
Q4 2017 -$4.25M -$1.17M Oct 1, 2017 Dec 31, 2017 10-K 2019-04-01
Q3 2017 -$1.5M -$1.07M -246% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$967K -$81.8K -9.23% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-13
Q1 2017 -$614K +$237K +27.9% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q3 2016 -$3.41M -$433K +$384K +47% Jul 1, 2016 Sep 30, 2016 10-Q 2016-11-14
Q2 2016 -$3.8M -$886K -$402K -83.3% Apr 1, 2016 Jun 30, 2016 10-Q 2016-08-04
Q1 2016 -$3.39M -$851K -$699K -461% Jan 1, 2016 Mar 31, 2016 10-Q 2016-05-09
Q4 2015 -$2.69M -$1.24M Oct 1, 2015 Dec 31, 2015 10-K 2016-03-30
Q3 2015 -$817K -$738K -942% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 -$483K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 -$152K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q3 2014 -$78.3K Jul 1, 2014 Sep 30, 2014 10-Q/A 2015-12-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.